Subclinical mastitis treatment for non-milking cows

Abstract

The article deals with the clinical research of cows during the interlactation period, through reviewing their medical histories and the clinical examination of the animals and their milk glands, trial milking and organoleptic evaluation of the secretion. The secretion was evaluated according to its color, texture, smell and the presence of foreign substances. The best therapeutic dosage of Vetom-3, a medicine based on Bacillus amyloliquefaciens, was determined through the examination of 30 non-milking cows suffering from subclinical mastitis. The probiotic and difumast were injected into the milk glands of the cows diagnosed with subclinical mastitis two weeks prior to the expected calving and in accordance with the examination results received on the 4th day of lactation. After the treatment, the milk was fed to the calves. The evaluation of the change rates of the microflora composition was carried out using calf feces samples. The bacteriological tests of the microflora were carried out using the standard procedures for determining the morphological properties of germ cultures. We ascertained that the use of Vetom-3, a medicine based on Bacillus amyloliquefaciens RNCIM V-10642 (DSM 24614), for the treatment of subclinical mastitis in non-milking cows allows to increase the efficiency of the treatment, as well as receive the milk of high sanitary quality, increase the survival rate of the newborn calves, and prevent dysbacteriosis and dyspepsy incidence in newborn calves.